Mirae Asset Global Investments Co., Ltd. Zai Lab LTD Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Zai Lab LTD stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,517 shares of ZLAB stock, worth $139,168. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,517
Previous 86,904
94.8%
Holding current value
$139,168
Previous $1.51 Million
92.76%
% of portfolio
0.0%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding ZLAB
# of Institutions
113Shares Held
40.9MCall Options Held
63.1KPut Options Held
420K-
Wellington Management Group LLP Boston, MA7.12MShares$220 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$201 Million0.06% of portfolio
-
Capital World Investors Los Angeles, CA5.31MShares$164 Million0.02% of portfolio
-
Woodline Partners LP San Francisco, CA2.33MShares$71.9 Million0.41% of portfolio
-
Viking Global Investors LP2.04MShares$62.8 Million0.14% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.02B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...